Skip to main content
Premium Trial:

Request an Annual Quote

Talis Biomedical Gets FDA Emergency Use Authorization for SARS-CoV-2 Point-of-Care Assay

NEW YORK — Talis Biomedical said on Monday that it has received Emergency Use Authorization from the US Food and Drug Administration for its Talis One COVID-19 point-of-care test.

The test is designed to detect the ORF1ab and N genes of SARS-CoV-2 in nasal swab specimens. It runs on the company's sample-to-answer Talis One molecular diagnostic system, which provides results in less than 30 minutes and was developed with funding under the National Institutes of Health's Rapid Acceleration of Diagnostics initiative.

Menlo Park, California-based Talis said earlier this year that it expects to manufacture up to 1 million of the SARS-CoV-2 tests per month before the end of the year. It is also developing tests for sexually transmitted diseases, women's health indications, and respiratory infections.





The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.